DNA methyltransferase I is a mediator of doxorubicin-induced genotoxicity in human cancer cells

Biochemical and Biophysical Research Communications

Volumn 382, Issue 2, 2009, Pages 462-467

  Tan, Hwee Hong ^a   Porter, Alan George ^a  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

5 Aza 2 deoxycytidine; Chemotherapy; DNMT1; Doxorubicin; Micronuclei; siRNA

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE 1; DOXORUBICIN;

ARTICLE; ATTENUATION; CANCER CELL; CELL CULTURE; CELL TYPE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG EFFICACY; FLOW CYTOMETRY; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MICRONUCLEUS; MICROSCOPY; PRIORITY JOURNAL; TUMOR CELL; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA DAMAGE; DOXORUBICIN; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICRONUCLEUS TESTS; NEOPLASMS;

EID: 63349098439     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.065     Document Type: Article

References (22)

1. Norppa H., and Falck G.C. What do human micronuclei contain?. Mutagenesis 18 (2003) 221-233
2. Hennig U.G., Rudd N.L., and Hoar D.I. Kinetochore immunofluorescence in micronuclei: a rapid method for the in situ detection of aneuploidy and chromosome breakage in human fibroblasts. Mutat. Res. 203 (1988) 405-414
3. Cornforth M.N., and Goodwin E.H. Transmission of radiation-induced acentric chromosomal fragments to micronuclei in normal human fibroblasts. Radiat. Res. 126 (1991) 210-217
4. Jagetia G.C., and Nayak V. Micronuclei-induction and its correlation to cell survival in HeLa cells treated with different doses of adriamycin. Cancer Lett. 110 (1996) 123-128
5. Hande K.R. Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim. Biophys. Acta 1400 (1998) 173-184
6. Swift L.P., Rephaeli A., Nudelman A., Phillips D.R., and Cutts S.M. Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death. Cancer Res. 66 (2006) 4863-4871
7. Potter A.J., and Rabinovitch P.S. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs. Mutat. Res. 572 (2005) 27-44
8. Kurz E.U., Douglas P., and Lees-Miller S.P. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J. Biol. Chem. 279 (2004) 53272-53281
9. Bean C.L., Armstrong M.J., and Galloway S.M. Effect of sampling time on chromosome aberration yield for 7 chemicals in Chinese hamster ovary cells. Mutat. Res. 265 (1992) 31-44
10. Eom Y.W., Kim M.A., Park S.S., Goo M.J., Kwon H.J., Sohn S., Kim W.H., Yoon G., and Choi K.S. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 24 (2005) 4765-4777
11. Hermann A., Goyal R., and Jeltsch A. The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J. Biol. Chem. 279 (2004) 48350-48359
12. Li E., Beard C., and Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 366 (1993) 362-365
13. Beard C., Li E., and Jaenisch R. Loss of methylation activates Xist in somatic but not in embryonic cells. Genes Dev. 9 (1995) 2325-2334
14. Li E., Bestor T.H., and Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69 (1992) 915-926
15. Chen T., Hevi S., Gay F., Tsujimoto N., He T., Zhang B., Ueda Y., and Li E. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat. Genet. 39 (2007) 391-396
16. Wolffe A.P., Jones P.L., and Wade P.A. DNA demethylation. Proc. Natl. Acad. Sci. USA 96 (1999) 5894-5896
17. Yokochi T., and Robertson K.D. Doxorubicin inhibits DNMT1, resulting in conditional apoptosis. Mol. Pharmacol. 66 (2004) 1415-1420
18. Palii S.S., Van Emburgh B.O., Sankpal U.T., Brown K.D., and Robertson K.D. DNA methylation inhibitor 5-Aza-2′-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol. Cell. Biol. 28 (2008) 752-771
19. Mortusewicz O., Schermelleh L., Walter J., Cardoso M.C., and Leonhardt H. Recruitment of DNA methyltransferase I to DNA repair sites. Proc. Natl. Acad. Sci. USA 102 (2005) 8905-8909
20. Le Gac G., Esteve P.O., Ferec C., and Pradhan S. DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase 1. J. Biol. Chem. 281 (2006) 24161-24170
21. Mishra M.V., Bisht K.S., Sun L., Muldoon-Jacobs K., Awwad R., Kaushal A., Nguyen P., Huang L., Pennington J.D., Markovina S., Bradbury C.M., and Gius D. DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells. Mol. Cancer Res. 6 (2008) 243-249
22. Egger G., Jeong S., Escobar S.G., Cortez C.C., Li T.W., Saito Y., Yoo C.B., Jones P.A., and Liang G. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proc. Natl. Acad. Sci. USA 103 (2006) 14080-14085